Products for Research Use Only
RegisterLogin

SARS-CoV-2-IN-45

CAT: 0804-HY-155015Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-155015Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
SARS-CoV-2-IN-45 (Compound 8p) is a SARS-CoV-2 inhibitor. SARS-CoV-2-IN-45 inhibits SARS-CoV-2 replication in Calu-3 cell with an EC50 of 0.5 μM, and has no evident cytotoxic effect[1].
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-in-45.html
Solubility
10 mM in DMSO
Smiles
O=C1C2=CC=C(OCOC)C=C2O/C1=C\C3=CC(OCOC)=C(OC)C=C3
Molecular Formula
C20H20O7
Molecular Weight
372.37
References & Citations
[1]Caleffi GS, et al. Aurones: A Promising Scaffold to Inhibit SARS-CoV-2 Replication. J Nat Prod. 2023 Jun 23;86 (6) :1536-1549.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-176211SARS-CoV-2 Mpro-IN-45
HY-135856-01SARS-CoV-IN-2
HY-156337SARS-CoV-2-IN-63
HY-143417SARS-CoV-2-IN-16
HY-162777SARS-CoV-2-IN-93
HY-162414SARS-CoV-2-IN-84
HY-148387SARS-CoV-2-IN-35
HY-168107SARS-CoV-2-IN-98
HY-162604SARS-CoV-2-IN-90
HY-155308SARS-CoV-2-IN-61

Alternative Products

CatalogName
MBS5820907SARS-CoV-2-IN-45
T210984-01SARS-CoV-2 Mpro-IN-45
CRB1001793-01SARS-CoV-2 NSP7 (31-45)
CRB1001793-01SARS-CoV-2 NSP7 (31-45) - (Antimicrobial Peptides - AMP)
GTR18678023-01SARS-CoV/SARS-CoV-2 Spike Antibody
BA1949-5SARS-CoV-IN-2
553226SARS-CoV-2
Oneq-S827-150RSARS CoV-2
C21524-50uLSARS-CoV/SARS-CoV-2 Nucleocapsid Antibody [E8H21]
GTR18595045-01SARS CoV/SARS CoV 2 Spike Human mAb

Popular Products